Anti-Chikungunya viral activities of aplysiatoxin-related compounds from the marine cyanobacterium Trichodesmium erythraeum

Marine Drugs

Volumn 12, Issue 1, 2014, Pages 115-127

  Gupta, Deepak Kumar ^a   Kaur, Parveen ^b   Leong, See Ting ^a   Tan, Lik Tong ^a   Prinsep, Michèle R ^c   Chu, Justin Jang Hann ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF WAIKATO   (New Zealand)

Author keywords

Antiviral; Aplysiatoxin; Chikungunya virus; Marine cyanobacterium; Trichodesmium erythraeum

Indexed keywords

3 METHOXYAPLYSIATOXIN; 3 METHOXYDEBROMOAPLYSIATOXIN; ANHYDRODEBROMOAPLYSIATOXIN; APLYSIATOXIN; DEBROMOAPLYSIATOXIN; MARINE TOXIN; RNA 16S; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CHIKUNGUNYA ALPHAVIRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYANOBACTERIUM; DRUG STRUCTURE; HUMAN; HUMAN CELL; MARINE BACTERIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYLOGENY; TRICHODESMIUM ERYTHRAEUM; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHIKUNGUNYA VIRUS; CRICETINAE; CYANOBACTERIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EUTROPHICATION; HUMANS; LYNGBYA TOXINS; MAGNETIC RESONANCE SPECTROSCOPY; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; VIRAL PLAQUE ASSAY;

EID: 84892897304     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12010115     Document Type: Article

References (26)

1. Gerwick, W.H.; Tan, L.T.; Sitachitta, N. Nitrogen-Containing Metabolites from Marine Cyanobacteria. Alkaloids Chem. Biol. 2001, 57, 75-184.
2. Tan, L.T. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry 2007, 68, 954-979.
3. Tan, L.T. Marine cyanobacteria: A treasure trove of bioactive secondary metabolites for drug discovery. Stud. Nat. Prod. Chem. 2012, 36, 67-110.
4. Tan, L.T. Pharmaceutical agents from filamentous marine cyanobacteria. Drug Discov. Today 2013, 18, 863-871.
5. Merel, S.; Walker, D.; Chicana, R.; Snyder, S.; Baures, E.; Thomas, O. State of knowledge and concerns on cyanobacterial blooms and cyanotoxins. Environ. Int. 2013, 59, 303-327.
6. Moore, R.E.; Blackman, A.J.; Cheuk, C.E.; Mynderse, J.S.; Mataumoto, G.K.; Clardy, J.; Woodard, R.W.; Craig, J.C. Absolute stereochemistries of the aplysiatoxins and oscillatoxin A. J. Org. Chem. 1984, 49, 2484-2489.
7. Chlipala, G.E.; Pham, H.T.; Nguyen, V.H.; Krunic, A.; Shim, S.H.; Soejarto, D.D.; Orjala, J. Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam. J. Nat. Prod. 2010, 73, 784-787.
8. Van Apeldoorn, M.E.; van Egmond, H.P.; Speijers, G.J.A.; Bakker, G.J.I. Toxins of cyanobacteria. Mol. Nutr. Food Res. 2007, 51, 7-60.
9. Nishizuka, Y. Discovery and prospect of protein kinase C research: Epilogue. J. Biochem. 2003, 133, 155-158.
10. Carter, C.A. Protein kinase C as a drug target: Implications for drug or diet prevention and treatment of cancer. Curr. Drug Targets 2000, 1, 163-183.
11. Nakagawa, Y.; Yanagita, R.C.; Hamada, N.; Murakami, A.; Takahashi, H.; Saito, N.; Irie, K. A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: Development of a synthetically accessible protein kinase C activator with bryostatin-like activity. J. Am. Chem. Soc. 2009, 131, 7573-7579.
12. Yanagita, R.C.; Kamachi, H.; Tanaka, K.; Murakami, A.; Nakagawa, Y.; Tokuda, H.; Nagai, H.; Irie, K. Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activity. Bioorg. Med. Chem. Lett. 2010, 20, 6064-6066.
13. Nakagawa, Y.; Kikumori, M.; Yanagita, R.C.; Murakami, A.; Tokuda, H.; Nagai, H.; Irie, K. Synthesis and biological evaluation of the 12,12-dimethyl derivative of Aplog-1, an anti-proliferative analog of tumor-promoting aplysiatoxin. Biosci. Biotechnol. Biochem. 2011, 75, 1167-1173.
14. Kikumori, M.; Yanagita, R.C.; Tokuda, H.; Suzuki, N.; Nagai, H.; Suenaga, K.; Irie, K. Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity. J. Med. Chem. 2012, 55, 5614-5626.
15. Irie, K.; Yanagita, R.C.; Nakagawa, Y. Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ. Med. Res. Rev. 2012, 32, 518-535.
16. Nakagawa, Y. Artificial analogs of naturally occurring tumor promotors as biochemical tools and therapeutic leads. Biosci. Biotechnol. Biochem. 2012, 76, 1262-1274.
17. Kamachi, H.; Tanaka, K.; Yanagita, R.C.; Murakami, A.; Murakami, K.; Tokuda, H.; Suzuki, N.; Nakagawa, Y.; Irie, K. Structure-activity studies on the side chain of a simplified analog of aplysiatoxin (aplog-1) with anti-proliferative activity. Bioorg. Med. Chem. 2013, 21, 2695-2702.
18. Yanagita, R.C.; Kamachi, H.; Kikumori, M.; Tokuda, H.; Suzuki, N.; Suenaga, K.; Nagai, H.; Irie, K. Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities. Bioorg. Med. Chem. Lett. 2013, 23, 4319-4323.
19. Hanaki, Y.; Kikumori, M.; Ueno, S.; Tokuda, H.; Suzuki, N.; Irie, K. Structure-activity studies at position 27 of aplog-1, a simplified analog of debromoaplysiatoxin with anti-proliferative activity. Tetrahedron 2013, 69, 7636-7645.
20. Sourisseau, M.; Schilte, C.; Casartelli, N.; Trouillet, C.; Guivel-Benhassine, F.; Rudnicka, D.; Sol-Foulon, N.; Le Roux, K.; Prevost, M.C.; Fsihi, H.; et al. Characterization of reemerging Chikungunya virus. PLoS Pathog. 2007, 3, e89.
21. Hapuarachchi, H.C.; Bandara, K.B.; Sumanadasa, S.D.; Hapugoda, M.D.; Lai, Y.L.; Lee, K.S.; Tan, L.K.; Lin, R.T.; Ng, L.F.; Bucht, G.; et al. Re-emergence of Chikungunya virus in South-east Asia: Virological evidence from Sri Lanka and Singapore. J. Gen. Virol. 2010, 91, 1067-1076.
22. Dupuis-Maguiraga, L.; Noret, M.; Brun, S.; Le Grand, R.; Gras, G.; Roques, P. Chikungunya disease: Infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl. Trop. Dis. 2012, 6, e1446.
23. Labadie, K.; Larcher, T.; Joubert, C.; Mannioui, A.; Delache, B.; Brochard, P.; Guigand, L.; Dubreil, L.; Lebon, P.; Verrier, B.; et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest. 2010, 120, 894-906.
24. Hawley, W.A.; Reiter, P.; Copeland, R.S.; Pumpuni, C.B.; Craig, G.B., Jr. Aedes albopictus in North America: Probable introduction in used tires from northern Asia. Science 1987, 236, 1114-1116.
25. Kaur, P.; Chu, J.J. Chikungunya virus: An update on antiviral development and challenges. Drug Discov. Today 2013, 18, 969-983.
26. Sorgeloos, P.; Remiche-Van Der Wielen, C.; Persoone, G. The use of Artemia nauplii for toxicity tests - A critical anaysis. Ecotoxicol. Environ. Saf. 1978, 2, 249-255.